Latest Trials
Latest News
Products
FAQ
Pharmaceutical Companies
Pharma Details
ALCON RESEARCH
🇺🇸
United States
Country
🇺🇸
United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 1
Not Applicable
Completed
Conditions
Hyperopia
Contact Lens Comfort
Myopia
Interventions
Device: Opti-Free® PureMoist® MPDS
Device: Biotrue™ MPS
Device: Habitual contact lenses
Subscribe
First Posted Date
2012-09-12
Last Posted Date
2014-04-17
Lead Sponsor
Alcon Research
Target Recruit Count
207
Registration Number
NCT01684033
Subscribe
Evaluation of the Effectiveness of Two Marketed Multi-Purpose Solutions for Silicone Hydrogel Contact Lenses - Study 2
Not Applicable
Completed
Conditions
Myopia
Contact Lens Comfort
Hyperopia
Interventions
Device: Opti-Free® PureMoist® MPDS
Device: RevitaLens MPDS
Device: Habitual Contact Lenses
Subscribe
First Posted Date
2012-09-12
Last Posted Date
2014-04-29
Lead Sponsor
Alcon Research
Target Recruit Count
196
Registration Number
NCT01684046
Subscribe
A Clinical Outcome Study of Two Multifocal Intraocular Lenses (IOL) in Cataract Patients
Not Applicable
Completed
Conditions
Cataracts
Interventions
Device: AcrySof® IQ ReSTOR® +2.5 D Multifocal IOL Model SN6AD2 [SV25T0]
Device: AcrySof® IQ ReSTOR® +3.0 D Multifocal IOL Model SN6AD1
Subscribe
First Posted Date
2012-09-12
Last Posted Date
2015-06-22
Lead Sponsor
Alcon Research
Target Recruit Count
112
Registration Number
NCT01684007
Subscribe
An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®
Phase 4
Completed
Conditions
Glaucoma
Ocular Hypertension
Interventions
Drug: Bimatoprost 0.01% ophthalmic solution
Drug: Travoprost 0.004% ophthalmic solution
Subscribe
First Posted Date
2012-08-14
Last Posted Date
2015-08-03
Lead Sponsor
Alcon Research
Target Recruit Count
104
Registration Number
NCT01664039
Subscribe
Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients
Phase 1
Completed
Conditions
Glaucoma
Ocular Hypertension
Interventions
Drug: Travoprost ophthalmic solution, 0.004% (new formulation)
Subscribe
First Posted Date
2012-08-07
Last Posted Date
2016-04-01
Lead Sponsor
Alcon Research
Target Recruit Count
25
Registration Number
NCT01658839
Subscribe
Study of Travoprost Ophthalmic Solution, 0.004% Compared to Timolol (0.5% or 0.25%) in Pediatric Glaucoma Patients
Phase 3
Completed
Conditions
Pediatric Glaucoma
Elevated IOP in Pediatric Patients
Ocular Hypertension in Pediatric Patients
Interventions
Drug: Timolol, 0.5% or 0.25% ophthalmic solution
Drug: Travoprost 0.004% PQ ophthalmic solution
Drug: Travoprost Vehicle
Subscribe
First Posted Date
2012-07-30
Last Posted Date
2015-07-23
Lead Sponsor
Alcon Research
Target Recruit Count
184
Registration Number
NCT01652664
Subscribe
A Prospective Study of Two Daily Disposable Contact Lenses
Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Delefilcon A contact lenses
Device: Etafilcon A contact lenses
Subscribe
First Posted Date
2012-07-10
Last Posted Date
2014-01-14
Lead Sponsor
Alcon Research
Target Recruit Count
62
Registration Number
NCT01636986
Subscribe
A Comparison of Silicone Hydrogel Contact Lenses: AIR OPTIX® COLORS Versus AIR OPTIX® AQUA
Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Lotrafilcon B contact lens with color
Device: Lotrafilcon B contact lens
Subscribe
First Posted Date
2012-07-10
Last Posted Date
2014-03-28
Lead Sponsor
Alcon Research
Target Recruit Count
258
Registration Number
NCT01635920
Subscribe
A Comparison of AIR OPTIX® COLORS Versus FRESHLOOK® COLORBLENDS
Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Phemfilcon A contact lens with color
Device: Lotrafilcon B contact lens with color
Subscribe
First Posted Date
2012-07-10
Last Posted Date
2014-05-09
Lead Sponsor
Alcon Research
Target Recruit Count
370
Registration Number
NCT01635933
Subscribe
Clinical Evaluation of Two Daily Disposable Silicone Hydrogel Contact Lenses
Not Applicable
Completed
Conditions
Myopia
Interventions
Device: Delefilcon A contact lenses (DAILIES TOTAL1®)
Device: Narafilcon B contact lenses (1-DAY ACUVUE® TruEye®)
Subscribe
First Posted Date
2012-07-06
Last Posted Date
2013-12-24
Lead Sponsor
Alcon Research
Target Recruit Count
330
Registration Number
NCT01634659
Subscribe
Prev
1
24
25
26
27
28
61
Next
© Copyright 2025. All Rights Reserved by MedPath
Home
Terms & Conditions
Privacy Policy